Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells

被引:394
作者
Duluc, Dorothee [1 ,10 ]
Delneste, Yves [1 ,10 ]
Tan, Fang [1 ,10 ]
Moles, Marie-Pierre [1 ,2 ,3 ,10 ]
Grimaud, Linda
Lenoir, Julien [1 ,2 ]
Preisser, Laurence
Anegon, Ignacio [4 ,5 ]
Catala, Laurent [6 ]
Ifrah, Norbert [2 ,3 ]
Descamps, Philippe [6 ]
Gamelin, Erick [1 ,7 ]
Gascan, Hugues [1 ]
Hebbar, Mohamed [8 ]
Jeannin, Pascale [1 ,9 ,10 ]
机构
[1] Univ Angers, Unite Rech Sante 564, Angers, France
[2] UPRES EA3863, Angers, France
[3] CHU Angers, Dept Malad Sang, Angers, France
[4] INSERM, UMR 643, Nantes, France
[5] Univ Nantes, Inst Transplantat & Rech Transplantat, FOCIS, Nantes, France
[6] CHU Angers, Dept Gynecol, Angers, France
[7] Ctr Lutte Contre Canc Paul Papin, Angers, France
[8] CHU Lille, Dept Oncol, F-59037 Lille, France
[9] CHU Angers, Lab Immunol & Allergol, Angers, France
[10] Ctr Hosp Univ, INSERM, Unit Equipe Avenir 564, F-49933 Angers, France
关键词
D O I
10.1182/blood-2007-02-072587
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tumor-associated macrophages (TAMs), the most abundant immunosuppressive cells in the tumor microenvironment, originate from blood monocytes and exhibit an IL-10(high)IL-12(low) M2 profile. The factors involved in TAM generation remain unidentified. We identify here leukemia inhibitory factor (LIF) and IL-6 as tumor microenvironmental factors that can promote TAM generation. Ovarian cancer ascites switched monocyte differentiation into TAM-like cells that exhibit most ovarian TAM functional and phenotypic characteristics. Ovarian cancer ascites contained high concentrations of LIF and IL-6. Recombinant LIF and IL-6 skew monocyte differentiation into TAM-like cells by enabling monocytes to consume monocyte-colony-stimulating factor (M-CSF). Depletion of LIF, IL-6, and M-CSF in ovarian cancer ascites suppressed TAM-like cell induction. We extended these observations to different tumor-cell line supernatants. In addition to revealing a new tumor-escape mechanism associated with TAM generation via LIF and IL-6, these findings offer novel therapeutic perspectives to subvert TAM-induced immunosuppression and hence improve T-cell-based antitumor immunotherapy efficacy.
引用
收藏
页码:4319 / 4330
页数:12
相关论文
共 68 条
[1]  
Allavena P, 1997, ADV EXP MED BIOL, V417, P323
[2]   Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer [J].
Almand, B ;
Clark, JI ;
Nikitina, E ;
van Beynen, J ;
English, NR ;
Knight, SC ;
Carbone, DP ;
Gabrilovich, DI .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :678-689
[3]  
Bernard C, 1999, CIRC RES, V85, P1124
[4]   A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation) [J].
Biswas, SK ;
Gangi, L ;
Paul, S ;
Schioppa, T ;
Saccani, A ;
Sironi, M ;
Bottazzi, B ;
Doni, A ;
Vincenzo, B ;
Pasqualini, F ;
Vago, L ;
Nebuloni, M ;
Mantovani, A ;
Sica, A .
BLOOD, 2006, 107 (05) :2112-2122
[5]   LEUKEMIA INHIBITORY FACTOR DERIVED FROM RAT COLON-CARCINOMA CELLS INCREASES HOST SUSCEPTIBILITY TO TUMOR-GROWTH [J].
BURG, C ;
PATRY, Y ;
LEPENDU, J ;
MOREAU, M ;
TESSON, L ;
GODARD, A ;
SOUILLOU, JP ;
MEFLAH, K ;
ANEGON, I .
CYTOKINE, 1995, 7 (08) :784-792
[6]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[7]   Tolerization of dendritic cells by TS cells:: the crucial role of inhibitory receptors ILT3 and ILT4 [J].
Chang, CC ;
Ciubotariu, R ;
Manavalan, JS ;
Yuan, J ;
Colovai, AI ;
Piazza, F ;
Lederman, S ;
Colonna, M ;
Cortesini, R ;
Dalla-Favera, R ;
Suciu-Foca, N .
NATURE IMMUNOLOGY, 2002, 3 (03) :237-243
[8]   Oncostatin M: a pleiotropic cytokine in the central nervous system [J].
Chen, SH ;
Benveniste, EN .
CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (05) :379-391
[9]   IL-6 switches the differentiation of monocytes from dendritic cells to macrophages [J].
Chomarat, P ;
Banchereau, J ;
Davoust, J ;
Palucka, AK .
NATURE IMMUNOLOGY, 2000, 1 (06) :510-514
[10]   Targeting myelomonocytic cells to revert inflammation-dependent cancer promotion [J].
Colombo, MP ;
Mantovani, A .
CANCER RESEARCH, 2005, 65 (20) :9113-9116